Shan Gao1, Jiaqi Huang1, Rui Zhao1

  • 1Department of Thoracic Surgery, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, China.

Heliyon
|October 14, 2024
PubMed
概括

这项研究开发了一种调节细胞死亡 (RCD) 风险模型,以预测肺腺癌 (LUAD) 患者的结果和免疫治疗的反应. 该模型识别了具有较差预后和免疫抑制瘤微环境的高风险患者.